AMR is BIG.
Our response is BIGGER.
From science to solutions
With our unique model, GARDP helps take antibiotic development from science to solutions.
We bring together governments, funders, researchers, industry and health workers to turn innovation into impact.
Every 6 seconds, a life is lost to antimicrobial resistance (AMR). Unless we develop innovative new antibiotics and ensure they reach the people who need them, AMR deaths are expected to surge by 70% by 2050.
This campaign is all about what happens next: a response that’s even bigger.
How we’re responding to AMR
Everyone, everywhere is at risk of developing a drug-resistant infection: new mothers in the labour ward, newborns whose immune systems are still developing, cancer patients whose treatment leaves them vulnerable, anyone undergoing routine surgery and everyone else. But with the right antibiotic innovation and access, we can protect them all.
From lab to labour ward
Testing new antibiotic combinations for newborns, so a breakthrough in the lab reaches babies before it’s too late.
From science to solutions
Turning early discoveries into treatments that actually reach the people who need them, not just the ones who can afford them.
From pipeline to patient
Licensing approved antibiotics for affordable, sustainable supply, so they can reach patients everywhere.
From infection to innovation
Targeting the toughest, most difficult-to-treat pathogens with innovative new antibiotics, not just variants of existing drugs already losing the fight.
From discovery to drugs
Leading and co-leading clinical trials through every phase, so promising compounds becomes proven treatments.
The world needs new antibiotics… now!
In the last century, antibiotics added 23 years to our average life expectancy. But now, drug-resistant infections are killing 4.71 million people a year, and without urgent action, that number could rise by 70% by 2050.
Partners make the response even bigger
No one individual, organization or government can solve this by themselves. GARDP works with over 150 partners across the public and private sectors, from funders and governments to research institutions and manufacturers, in equal partnership between the Global North and Global South.
Campaign materials
Join us
The scale of AMR demands collaboration across sectors, disciplines and borders. Whether you help fund the science, invest in the model or partner on delivery, you become part of the response that’s already saving lives, and will help save millions more.
Donate
To help protect people everywhere from the rise and spread of drug-resistant infections.
Invest
In a proven model that’s already delivering, and built to scale.
Partner
With GARDP to bring next-generation antibiotics to everyone, everywhere.